Replies to post #1097 on AVANIR PHARMACEUTICALS (AVNR)

[stocksablaze]

missed vnda. watched the entire thing though lol..

i think this move has a lot more to do with trial results..

Avanir Pharma [AVNR: 0.96, 0.00 (0.00%)]: AVNR completed targeted enrollment on 3/16/09 of patients into the STAR trial, a pivotal Phase 3 trial of Zenvia (dextromethorphan/quinidine) in patients exhibiting signs and symptoms of pseudobulbar affect. The randomized, multi-center, international STAR trial is designed to compare the effects of Zenvia 30/10 mg, Zenvia 20/10 mg and placebo on involuntary crying/laughing episodes rates. AVNR expects to release topline data no later than end of 3Q09 and plans to submit a complete response to the FDA approvable letter during 1H10.